KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Receivables - Other (2016 - 2021)

Quest Diagnostics' Receivables - Other history spans 9 years, with the latest figure at $5.0 million for Q1 2021.

  • For Q1 2021, Receivables - Other changed 0.0% year-over-year to $5.0 million; the TTM value through Mar 2021 reached $5.0 million, changed 0.0%, while the annual FY2020 figure was $3.0 million, 25.0% down from the prior year.
  • Receivables - Other for Q1 2021 was $5.0 million at Quest Diagnostics, up from $3.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $13.0 million in Q2 2017 and bottomed at $2.0 million in Q1 2019.
  • The 5-year median for Receivables - Other is $4.0 million (2018), against an average of $4.6 million.
  • The largest annual shift saw Receivables - Other tumbled 76.92% in 2018 before it skyrocketed 150.0% in 2020.
  • A 5-year view of Receivables - Other shows it stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then soared by 33.33% to $4.0 million in 2019, then fell by 25.0% to $3.0 million in 2020, then surged by 66.67% to $5.0 million in 2021.
  • Per Business Quant, the three most recent readings for DGX's Receivables - Other are $5.0 million (Q1 2021), $3.0 million (Q4 2020), and $4.0 million (Q3 2020).